Patient burden and clinical advances associated with postapproval monotherapy cancer drug trials: a retrospective cohort study
ObjectivesAfter regulatory approval, drug companies, public funding agencies and academic researchers often pursue trials aimed at extending the uses of a new drug by testing it in new non-approved indications. Patient burden and clinical impact of such research are not well understood.Design and se...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-02-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/2/e034306.full |